VanEck Biotech ETF
BBH
59 hedge funds and large institutions have $151M invested in VanEck Biotech ETF in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 6 closing their positions.
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
117% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 12
36% more capital invested
Capital invested by funds: $112M → $151M (+$39.7M)
13% more funds holding
Funds holding: 52 → 59 (+7)
2.97% more ownership
Funds ownership: 23.41% → 26.38% (+3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less call options, than puts
Call options by funds: $4.56M | Put options by funds: $4.64M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$21.2M |
| 2 |
Goldman Sachs
New York
|
+$12.2M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.4M |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$3.34M |
| 5 |
WJA
Williams Jones & Associates
New York
|
+$2.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$5.97M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.66M |
| 3 |
AP
Advisors Preferred
Rockville,
Maryland
|
-$2.74M |
| 4 |
FMI
Factory Mutual Insurance
Waltham,
Massachusetts
|
-$2.66M |
| 5 |
NES
New England Securities
New York
|
-$911K |
BBH Hedge Fund Activity: Q1 2014 in Review
59 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2014, worth a combined $151M — up 36% from $112M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new BBH positions and 6 closed out — a net gain of 7 holders — while 26 added to existing stakes and 12 trimmed.
The largest buyer was Credit Suisse, adding an estimated $21.2M. The largest seller was Bank of Montreal, cutting an estimated $5.97M.
- 59 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2014, up from 52 in Q4 2013.
- Funds reported $151M of VanEck Biotech ETF stock for Q1 2014, up 36% quarter-over-quarter.
- 13 funds opened new VanEck Biotech ETF positions in Q1 2014 and 6 closed out, a net change of +7 holders.
- The largest VanEck Biotech ETF buyer in Q1 2014 was Credit Suisse, an estimated $21.2M added.
- The largest VanEck Biotech ETF seller in Q1 2014 was Bank of Montreal, an estimated $5.97M sold.
Based on aggregated 13F filings for Q1 2014.